Optic nerve sheath meningiomas in patients with neurofibromatosis type 2

Archives of Ophthalmology

Volumn 124, Issue 3, 2006, Pages 379-385

  Bosch, Martina M ^a   Wichmann, Werner W ^b   Boltshauser, Eugen ^c   Landau, Klara ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Im Park Hospital   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MENINGIOMA; NEUROFIBROMATOSIS; NEURORADIOLOGY; OPHTHALMOLOGY; OPTIC NERVE TUMOR; PATIENT REFERRAL; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MENINGIOMA; MIDDLE AGED; NEUROFIBROMATOSIS 2; OPTIC NERVE NEOPLASMS; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 33644916117     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.124.3.379     Document Type: Article

References (72)

1. Evans DG, Huson SM, Donnai D, et al. A genetic study of type 2 neurofibromatosis in the United Kingdom, I: prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet. 1992;29:841-846.
2. Trofatter JA, MacCollin MM, Rutter JL, et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell. 1993;72:791-800.
3. Rouleau GA, Merel P, Lutchman M, et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993;363:515-521.
4. Parry DM, Eldridge R, Kaiser-Kupfer MI, Bouzas EA, Pikus A, Patronas N. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet. 1994;52:450-461.
5. Evans DG, Huson SM, Donnai D, et al. A clinical study of type 2 neurofibromatosis. Q J Med. 1992;84:603-618.
6. Martuza RL, Eldridge R. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med. 1988;318:684-688.
7. National Institutes of Health Consensus Development Conference. Neurofibromatosis: conference statement. Arch Neurol. 1988;45:575-578.
8. Kaiser-Kupfer MI, Freidlin V, Datiles MB, et al. The association of posterior capsular lens opacities with bilateral acoustic neuromas in patients with neurofibromatosis type 2. Arch Ophthalmol. 1989;107:541-544.
9. Landau K, Yasargil GM. Ocular fundus in neurofibromatosis type 2. Br J Ophthalmol. 1993;77:646-649.
10. Ragge NK, Baser ME, Riccardi VM, Falk RE. The ocular presentation of neurofibromatosis 2. Eye. 1997;11:12-18.
11. Wright JE. Primary optic nerve meningiomas: clinical presentation and management. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 1977;83:617-625.
12. Wright JE, Call NB, Liaricos S. Primary optic nerve meningioma. Br J Ophthalmol. 1980;64:553-558.
13. Sibony PA, Krauss HR, Kennerdell JS, Maroon JC, Slamovits TL. Optic nerve sheath meningiomas: clinical manifestations. Ophthalmology. 1984;91:1313-1326.
14. Alper MG. Management of primary optic nerve meningiomas: current status: therapy in controversy. J Clin Neuroophthalmol. 1981;1:101-117.
15. Dutton JJ. Optic nerve sheath meningiomas. Surv Ophthalmol. 1992;37:167-183.
16. Hollenhorst RW Jr, Hollenhorst RW Sr, MacCarty CS. Visual prognosis of optic nerve sheath meningiomas producing shunt vessels on the optic disk: the Hoyt-Spencer syndrome. Trans Am Ophthalmol Soc. 1977;75:141-163.
17. Frisen L, Hoyt WF, Tengroth BM. Optociliary veins, disc pallor and visual loss: a triad of signs indicating spheno-orbital meningioma. Acta Ophthalmol (Copenh). 1973;51:241-249.
18. Viskochil D, Buchberg AM, Xu G, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990;62:187-192.
19. Seizinger BR, Rouleau GA, Ozelius LJ, et al. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell. 1987;49:589-594.
20. Rouleau GA, Wertelecki W, Haines JL, et al. Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature. 1987;329:246-248.
21. Cawthon RM, Weiss R, Xu GF, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990;62:193-201.
22. Wallace MR, Marchuk DA, Andersen LB, et al. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990;249:181-186.
23. Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales. Brain. 1988;111:1355-1381.
24. McGaughran JM, Harris DI, Donnai D, et al. A clinical study of type 1 neurofibromatosis in north west England. J Med Genet. 1999;36:197-203.
25. Halliday AL, Sobel RA, Martuza RL. Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg. 1991;74:248-253.
26. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology. 2002;59:1759-1765.
27. Gardner WJ, Frazier CH. Bilateral acoustic neurofibromas: a clinical study and field survey of a family of five generations with bilateral deafness in thirty-eight members. Arch Neurol Psychiatry. 1930;23:266-302.
28. Wishart J. Case of tumours in the skull, dura mater, and brain. Edinburgh Med Surg J. 1822;18:393-397.
29. Swenson SA, Forbes GS, Younge BR, Campbell RJ. Radiologic evaluation of tumors of the optic nerve. AJNR Am J Neuroradiol. 1982;3:319-326.
30. Kanamalla US. The optic nerve tram-track sign. Radiology. 2003;227:718-719.
31. Johns TT, Citrin CM, Black J, Sherman JL. CT evaluation of perineural orbital lesions: evaluation of the "tram-track" sign. AJNR Am J Neuroradiol. 1984;5:587-590.
32. Lindblom B, Norman D, Hoyt WF. Perioptic cyst distal to optic nerve meningioma: MR demonstration. AJNR Am J Neuroradiol. 1992;13:1622-1624.
33. Miller N, Newman N. Tumors of the meninges and related tissues: meningiomas and sarcomas. In: Hoyt W, Walsh F, eds. Walsh and Hoyt's Clinical Neuroophthalmology. 5th ed. Philadelphia, Pa: Williams & Wilkins; 1998:2044-2051.
34. Wilson WB. Meningiomas of the anterior visual system. Surv Ophthalmol. 1981;26:109-127.
35. Mafee MF, Goodwin J, Dorodi S. Optic nerve sheath meningiomas: role of MR imaging. Radiol Clin North Am. 1999;37:37-58.
36. Daniels DL, Mark LP, Mafee MF, et al. Osseous anatomy of the orbital apex. AJNR Am J Neuroradiol. 1995;16:1929-1935.
37. Consensus Development Panel. National Institutes of Health Consensus Development Conference Statement on Acoustic Neuroma, December 11-13, 1991. Arch Neurol. 1994;51:201-207.
38. Brodsky MC, Landau K, Wilson RS, Boltshauser E. Morning glory disc anomaly in neurofibromatosis type 2. Arch Ophthalmol. 1999;117:839-841.
39. Parker H. A case of von Recklinghausen's disease with involvement of the peripheral nerves, optic nerve and spinal cord. J Nerv Ment Dis. 1922;56:441-452.
40. Hartmann E. Enlargissement du canal optique visible à la radiographie chez les malades atteints de neurofibromatose avec tumeur du nerf optique. J Belge Neurol Psychiatr. 1933;33:763-772.
41. Shapland CD, Greenfield JG. Case of neurofibromatosis with meningeal tumor involving left optic nerve. Trans Ophthalmol Soc U K. 1935;55:257-279.
42. Worster-Drought C, Dickson WEC, McMenemey WH. Multiple meningeal and perineural tumors with analagous changes in the glia and ependyma (neurofibroblastomatosis), with report of two cases. Brain. 1937;60:85-117.
43. Als E. Intraorbital menigiomas encasing the optic nerve. Acta Ophthalmol (Copenh). 1969;47:900-903.
44. Walsh F. Meningiomas primary within the orbit and optic canal. In: Smith JL, ed. Neuro-ophthalmology Symposium of the University of Miami and the Bascom Palmer Eye Institute. St Louis, Mo: Mosby; 1970:240-266.
45. Karp LA, Zimmerman LE, Borit A, Spencer W. Primary intraorbital meningiomas. Arch Ophthalmol. 1974;91:24-28.
46. Jakobiec FA, Depot MJ, Kennerdell JS, et al. Combined clinical and computed tomographic diagnosis of orbital glioma and meningioma. Ophthalmology. 1984;91:137-155.
47. Cibis GW, Whittaker CK, Wood WE. Intraocular extension of optic nerve meningioma in a case of neurofibromatosis. Arch Ophthalmol. 1985;103:404-406.
48. Wright JE, McNab AA, McDonald WI. Primary optic nerve sheath meningioma. Br J Ophthalmol. 1989;73:960-966.
49. Cunliffe IA, Moffat DA, Hardy DG, Moore AT. Bilateral optic nerve sheath meningiomas in a patient with neurofibromatosis type 2. Br J Ophthalmol. 1992;76:310-312.
50. Bouzas EA, Parry DM, Eldridge R, Kaiser-Kupfer MI. Visual impairment in patients with neurofibromatosis 2. Neurology. 1993;43:622-623.
51. Meyers SM, Gutman FA, Kaye LD, Rothner AD. Retinal changes associated with neurofibromatosis 2. Trans Am Ophthalmol Soc. 1995;93:245-252.
52. Ragge NK, Baser ME, Klein J, et al. Ocular abnormalities in neurofibromatosis 2. Am J Ophthalmol. 1995;120:634-641.
53. Mautner VF, Lindenau M, Baser ME, et al. The neuroimaging and clinical spectrum of neurofibromatosis 2. Neurosurgery. 1996;38:880-885.
54. Lewis RA, Gerson LP, Axelson KA, Riccardi VM, Whitford RP. von Recklinghausen neurofibromatosis, II: incidence of optic gliomata. Ophthalmology. 1984;91:929-935.
55. Hochstrasser H, Boltshauser E, Valavanis A. Brain tumors in children with von Recklinghausen neurofibromatosis. Neurofibromatosis. 1988;1:233-239.
56. Listernick R, Charrow J, Greenwald MJ, Esterly NB. Optic gliomas in children with neurofibromatosis type 1. J Pediatr. 1989;114:788-792.
57. Lund AM, Skovby F. Optic gliomas in children with neurofibromatosis type 1. Eur J Pediatr. 1991;150:835-838.
58. Davis FA. Primary tumors of the optic nerve (a phenomenon of Recklinghausen's disease). Arch Ophthalmol. 1940;23:957-1022.
59. Evans DG, Birch JM, Ramsden RT. Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child. 1999;81:496-499.
60. Jackson A, Patankar T, Laitt RD. Intracanalicular optic nerve meningioma: a serious diagnostic pitfall. AJNR Am J Neuroradiol. 2003;24:1167-1170.
61. Wichmann W. Reflexions about imaging technique and examination protocol 2: MR-examination protocol. Eur J Radiol. 2004;49:6-7.
62. Turbin RE, Thompson CR, Kennerdell JS, Cockerham KP, Kupersmith MJ. A long-term visual outcome comparison in patients with optic nerve sheath meningioma managed with observation, surgery, radiotherapy, or surgery and radiotherapy. Ophthalmology. 2002;109:890-900.
63. Pitz S, Becker G, Schiefer U, et al. Stereotactic fractionated irradiation of optic nerve sheath meningioma: a new treatment alternative. Br J Ophthalmol. 2002;86:1265-1268.
64. Egan RA, Lessell S. A contribution to the natural history of optic nerve sheath meningiomas. Arch Ophthalmol. 2002;120:1505-1508.
65. Saeed P, Rootman J, Nugent RA, White VA, Mackenzie IR, Koornneef L. Optic nerve sheath meningiomas. Ophthalmology. 2003;110:2019-2030.
66. Long DM. Neurosurgical involvement in tumors of the orbit. Clin Neurosurg. 1985;32:514-523.
67. Narayan S, Cornblath WT, Sandler HM, Elner V, Hayman JA. Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2003;56:537-543.
68. Andrews DW, Faroozan R, Yang BP, et al. Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery. Neurosurgery. 2002;51:890-904.
69. Liu JK, Forman S, Hershewe GL, Moorthy CR, Benzil DL. Optic nerve sheath meningiomas: visual improvement after stereotactic radiotherapy. Neurosurgery. 2002;50:950-955.
70. Becker G, Jeremic B, Pitz S, et al. Stereotactic fractionated radiotherapy in patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys. 2002;54:1422-1429.
71. Eng TY, Albright NW, Kuwahara G, et al. Precision radiation therapy for optic nerve sheath meningiomas. Int J Radiat Oncol Biol Phys. 1992;22:1093-1098.
72. Subramanian PS, Bressler NM, Miller NR. Radiation retinopathy after fractionated stereotactic radiotherapy for optic nerve sheath meningioma. Ophthalmology. 2004;111:565-567.